Valink Therapeutics Closes $11.8 Million Pre-A Financing Round to Advance Oncology Pipeline
Funding accelerates development of novel therapeutics to improve outcomes for patients with cancer CAMBRIDGE, Mass. & LONDON–(BUSINESS WIRE)–Valink Therapeutics Inc. (“Valink”), a private biotechnology company developing next-generation oncology therapeutics with a focus on bispecific antibody-drug…